Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Gallo: FLSC Phase I & II Clinical Trials |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2012-11-01 |
| Study Made Public: | 2015-02-03 |
Title
Challenge Study to evaluate an effective preventative HIV vaccine and booster regimen
Description
CAVD 391 is a non-human primate challenge study of a prime/boost regimen using an ALVAC-HIV viral vector (vCP1521), rhFLSC protein, and adjuvant.
Sign in to see full information about this study and to download study data.
Products
rhFLSC Protein ALVAC (vCP1521) GLA-SE (IDRI-EM005) SHIV162p3 Placebo ALVACIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.